Form 4 for CNMD CONMED Corp
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001127602-22-008585 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-08 | 2022-03-04 | CNMD | Jonas Daniel S | EVP Legal Affairs, Gen. Counsel | M - OptEx | $65.46 | +21.8K | 15.8K | New | +$1.42M |
| DM | 2022-03-08 | 2022-03-04 | CNMD | Jonas Daniel S | EVP Legal Affairs, Gen. Counsel | S - Sale+OE | $142.54 | -21.8K | 12.2K | -64% | -$3.10M |
| DM | 2022-03-08 | 2022-03-04 | CNMD | Jonas Daniel S | EVP Legal Affairs, Gen. Counsel | M - OptEx | $0.00 | -21.8K | 5,400 | -80% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-04 | M | A | 5,600 | $59.96 | 17,767 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-04 | S | D | 11,157 | $142.50 | 12,167 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-04 | M | A | 11,157 | $78.76 | 23,324 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-04 | M | A | 1,390 | $41.93 | 13,557 | D | — | — | |
| 5 | Common | Common Stock | 2022-03-04 | S | D | 1,390 | $143.30 | 12,167 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.28 to $143.34. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 6 | Common | Common Stock | 2022-03-04 | M | A | 3,610 | $41.93 | 15,777 | D | — | — | |
| 7 | Common | Common Stock | 2022-03-04 | S | D | 3,610 | $142.42 | 12,167 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.40 to $142.54. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 8 | Common | Common Stock | 2022-03-04 | S | D | 5,600 | $142.50 | 12,167 | D | — | — | |
| 9 | Derivative | Options To Purchase Common Stock | 2022-03-04 | M | D | 3,610 | $0.00 | 0 | D | $41.93 · — to 2027-03-01 | 3,610 Common Stock | (F3) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| 10 | Derivative | Options To Purchase Common Stock | 2022-03-04 | M | D | 11,157 | $0.00 | 10,000 | D | $78.76 · — to 2029-03-01 | 11,157 Common Stock | (F4) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 11 | Derivative | Options To Purchase Common Stock | 2022-03-04 | M | D | 1,390 | $0.00 | 3,610 | D | $41.93 · — to 2027-03-01 | 1,390 Common Stock | (F3) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| 12 | Derivative | Options To Purchase Common Stock | 2022-03-04 | M | D | 5,600 | $0.00 | 5,400 | D | $59.96 · — to 2028-03-01 | 5,600 Common Stock | (F3) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |